Tesaro Revenue, Growth & Competitor Profile

DBA C/O GLAXOSMITHKLINE

Company Profile & Annual Report for Tesaro

Access the complete profile.

Tesaro Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	1000 Winter Street North Suite 3300 Waltham, MA 02451

Tesaro's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tesaro's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Tesaro is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Tesaro is a publicly traded company on NMS using the ticker symbol TSRO. Detailed information on company financials and operating reports can be found here: NMS: TSRO

Tesaro Annual Revenue and Growth Rate

Tesaro	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Tesaro's revenues are gauged from an analysis of company filings.

Investor Activity

Tesaro has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 18, 2016	1	100%	$50 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Tesaro is developing and marketing. Tesaro doesn't have any recent trademark applications, indicating Tesaro is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
JEMPERLI Pharmaceutical preparations for the treatment and prevention of cancer	08/21/2019
VUPERLA Pharmaceutical preparations for the treatment and prevention of cancer	08/21/2019
JEMPURLI Biological preparations for the treatment of cancer	07/01/2019

See all trademarks and details in the Full Report.

Market Share of Tesaro's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tesaro, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Tesaro. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELEVATEBIO IPSC	Waltham, MA	100
IMMUNOGEN	Waltham, MA	36
BOSTON IVF	Waltham, MA	34
NPS PHARMACEUTICALS	Lexington, MA	32
CLINICAL SERVICES CORPORATE OPERATIONS	Waltham, MA	20
FOSTER-MILLER	Waltham, MA	15

Future Competition: Tesaro's Fastest Growing Competitors

These companies are in the same general field as Tesaro and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)